With close to 1 million subscribers worldwide, Jeff Brown is one of the better known financial advisors and investment newsletters writers in the world. In a recent newsletter, Jeff teases a “genetic therapy biotech company” that he thinks will secure FDA approval within the next couple of months and whose shares will skyrocket as a

Read More